Institutional Investment Pitches
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Initially invested in as a PIPE a year ago, it ended the quarter as the fund's largest holding. CEO Brad Jacobs...
— Christina Siegel Malbon
Full equity research memos, financial breakdowns, and hedge fund thesis write-ups are reserved for BSD Research ($50/mo) and Pro subscribers.
Already a Research or Pro subscriber? Sign In
Other investors who've written on QXO, Inc.
One such stock was building products distributor QXO, which proved to be a detractor for the quarter. We initiated our...
Added in April, QXO fell after announcing its acquisition of TopBuild due to market concerns over leverage and integration. However, the manager...
QXO (QXO) shares underperformed during the period as investors remained focused on near-term macroeconomic headwinds, including a sluggish U.S. housing market and persistently elevated interest rates,
More institutional theses from Patient Capital Management
Delta Air Lines experienced a strong late-year rally as the broader market finally recognized its healthy consumer demand and solid fundamentals. This holding exemplifies...
Precigen is an undervalued cell and gene therapy company poised for its first FDA approval later this year. A recent private...
The fund initiated a position in the Bitcoin ETF, believing the digital asset is still in the early stages of its adoption lifecycle. Despite its recent...